UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  May 15, 2018

 

 

ZIMMER BIOMET HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-16407

13-4151777

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

 

345 East Main Street

Warsaw, Indiana 46580

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:  (574) 267-6131

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 


Item 5.07

Submission of Matters to a Vote of Security Holders

 

Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 15, 2018.  Shareholders took the following actions:

 

elected nine (9) directors for one-year terms ending at the 2019 annual meeting of shareholders (Proposal 1);

 

ratified the Audit Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2018 (Proposal 2); and

 

approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement (Proposal 3).

 

The vote tabulation for each proposal follows:

 

Proposal 1 – Election of Directors

 

Nominee

 

For

 

Against

 

Abstained

 

Broker Non-Votes

 

Christopher B. Begley

 

160,254,308

 

643,499

 

135,080

 

14,621,693

 

Betsy J. Bernard

 

158,930,818

 

1,950,061

 

152,008

 

14,621,693

 

Gail K. Boudreaux

 

159,022,587

 

1,860,833

 

149,467

 

14,621,693

 

Michael J. Farrell

 

158,814,927

 

2,059,435

 

158,525

 

14,621,693

 

Larry C. Glasscock

 

157,507,457

 

3,365,367

 

160,063

 

14,621,693

 

Robert A. Hagemann

 

159,818,782

 

1,074,417

 

139,688

 

14,621,693

 

Bryan C. Hanson

 

160,156,645

 

737,391

 

138,851

 

14,621,693

 

Arthur J. Higgins

 

124,667,635

 

36,228,637

 

136,615

 

14,621,693

 

Michael W. Michelson

 

160,234,599

 

656,124

 

142,164

 

14,621,693

 

 

Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm

 

For

 

Against

 

Abstained

 

Broker Non-Votes

 

173,027,223

 

2,484,868

 

142,489

 

0

 

 

Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”)

 

For

 

Against

 

Abstained

 

Broker Non-Votes

 

150,630,503

 

10,007,744

 

394,640

 

14,621,693

 

 

 

 

 

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:  May 21, 2018

 

 

ZIMMER BIOMET HOLDINGS, INC.

 

 

 

 

By:

/s/ Chad F. Phipps

 

Name:

Chad F. Phipps

 

Title:

Senior Vice President, General Counsel and Secretary